A 5 years old child is presented to the Child and Adolescent Psychiatry Unit by her mother. The history shows that the child has hyperactivity, impulsive behavior, poor attention, fidgeting, and impaired concentration. What medication would you expect to be prescribed for the child?

1. A

   Chlorpromazine

2. B

   Chlordiazepoxide

3. C

   Lamotrigine

4. D

   Atomoxetine

Appeared in: RUHS, Jaipur, PB B.Sc Nursing Entrance-2019

Explanation

• The clinical presentation with hyperactivity, impulsivity, and poor concentration is a classic picture of Attention-Deficit/Hyperactivity Disorder (ADHD).
• Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI), a non-stimulant medication specifically approved for the treatment of ADHD in children and adolescents.
• It works by increasing the levels of norepinephrine, a neurotransmitter in the brain that is thought to play a role in attention and behavior control.
• While stimulant medications are often the first-line treatment, atomoxetine is a valuable alternative, particularly for patients who have a poor response to, or side effects from, stimulants, or when there is a concern for substance abuse.

Why Other Options Were Wrong

• Option A: Chlorpromazine is a typical antipsychotic medication. Its primary use is for treating psychosis (e.g., in schizophrenia) and managing severe agitation. It is not indicated for the core symptoms of ADHD.
• Option B: Chlordiazepoxide is a benzodiazepine, primarily used as an anxiolytic to treat anxiety disorders and for managing symptoms of alcohol withdrawal. It can cause sedation and has a potential for dependence, making it unsuitable for ADHD.
• Option C: Lamotrigine is an anticonvulsant and mood stabilizer. It is used to prevent seizures in epilepsy and to stabilize mood in bipolar disorder. It does not target the neurotransmitter pathways primarily involved in ADHD.

Related Visual

Clinical Relevance

• Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacological management of Attention-Deficit/Hyperactivity Disorder (ADHD) in children as background academic context rather than a clinical decision trigger.
• Nurses play a vital role in educating families about ADHD medications. For atomoxetine, it's crucial to explain that improvement is gradual over several weeks, which manages family expectations and promotes treatment adherence.
• A key nursing responsibility is monitoring for adverse effects, especially the FDA black box warning for increased risk of suicidal ideation in children and adolescents. Any report of worsening mood or suicidal thoughts requires immediate escalation.
• Baseline and ongoing monitoring of weight, height, heart rate, and blood pressure are essential safety measures for children on long-term ADHD medication.

How to Approach the Question

• First, identify the core clinical syndrome from the list of symptoms provided in the question. The combination of hyperactivity, impulsivity, and poor attention points directly to ADHD.
• Next, recall the main classes of medications used to treat ADHD. These include stimulants (e.g., methylphenidate) and non-stimulants (e.g., atomoxetine, alpha-2 agonists).
• Review each of the four options and classify them based on their drug class and primary use.
• Eliminate the options that are clearly incorrect for treating ADHD: Chlorpromazine (antipsychotic), Chlordiazepoxide (anxiolytic), and Lamotrigine (anticonvulsant/mood stabilizer).
• This process of elimination leaves Atomoxetine, which is a known non-stimulant treatment for ADHD, as the correct answer.

Concept Tested & Keywords

• Concept Tested: Pharmacological management of Attention-Deficit/Hyperactivity Disorder (ADHD) in children.
• Stem keywords: 5 years old child, hyperactivity, impulsive behavior, poor attention, fidgeting, impaired concentration
• Lead-in keywords: What medication
• Clinical cues: The combination of hyperactivity, impulsivity, and inattention strongly suggests a diagnosis of ADHD.
• Negative lead-in flag: false

Question ID

QHGBSR01gdCTpXwHBB-Wof

Copy ID

Reference Book

E6 Kaplan Sadock's Synopsis of Psychiatry-2022 (pp 1-3768 of 3768) p. 437-439

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 269-271